SureTrader
Home > Boards > US Listed > Medical - Drugs > Valeant Pharmaceuticals International (VRX)

Hey I'd be happy with $25 - $30

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
ChrisJP Member Profile
Member Level 
Followed By 92
Posts 28,701
Boards Moderated 2
Alias Born 08/02/00
160x600 placeholder
Bausch + Lomb Reports More Than Two Million Used Contact Lens Materials Recycled Through ONE by ONE Program PR Newswire (Canada) - 4/19/2018 8:00:00 AM
Bausch + Lomb Reports More Than Two Million Used Contact Lens Materials Recycled Through ONE by ONE Program PR Newswire (US) - 4/19/2018 8:00:00 AM
Valeant Announces Redemption of $150 Million Aggregate Principal Amount of Its Outstanding 6.375% Senior Unsecured Notes Due ... PR Newswire (Canada) - 4/12/2018 4:15:00 PM
Valeant Announces Redemption of $150 Million Aggregate Principal Amount of Its Outstanding 6.375% Senior Unsecured Notes Due ... PR Newswire (US) - 4/12/2018 4:15:00 PM
Arbitral Tribunal Decides In Favor Of Valeant In UCERIS Arbitration PR Newswire (Canada) - 4/12/2018 2:51:00 PM
Arbitral Tribunal Decides In Favor Of Valeant In UCERIS Arbitration PR Newswire (US) - 4/12/2018 2:51:00 PM
Bausch + Lomb to Showcase New Scientific Data During the Annual Meeting of the American Society of Cataract and Refractive Su... PR Newswire (Canada) - 4/11/2018 8:00:00 AM
Bausch + Lomb to Showcase New Scientific Data During the Annual Meeting of the American Society of Cataract and Refractive Su... PR Newswire (US) - 4/11/2018 8:00:00 AM
Valeant And One Of Its Subsidiaries Announce Expiration And Final Settlement Date For Cash Tender Offers For Senior Notes PR Newswire (Canada) - 4/10/2018 7:33:00 PM
Valeant And One Of Its Subsidiaries Announce Expiration And Final Settlement Date For Cash Tender Offers For Senior Notes PR Newswire (US) - 4/10/2018 7:33:00 PM
Ortho Dermatologics Announces Publication Of Pivotal Efficacy And Safety Data For Psoriasis Treatment DUOBRII™ In The Journ... PR Newswire (Canada) - 4/9/2018 7:00:00 AM
Ortho Dermatologics Announces Publication Of Pivotal Efficacy And Safety Data For Psoriasis Treatment DUOBRII™ In The Journ... PR Newswire (US) - 4/9/2018 7:00:00 AM
EyeGate Completes Enrollment and Receives Milestone Payment for Confirmatory Phase 3 Clinical Study of EGP-437 in Anterior Uv... GlobeNewswire Inc. - 4/6/2018 8:30:00 AM
Valeant Will Release First-Quarter 2018 Financial Results On May 8 PR Newswire (Canada) - 4/6/2018 8:00:00 AM
Valeant Will Release First-Quarter 2018 Financial Results On May 8 PR Newswire (US) - 4/6/2018 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/3/2018 5:10:12 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/3/2018 5:03:11 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/3/2018 5:00:42 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/3/2018 5:00:15 PM
Salix Launches 'Let's Talk 2' IBS Awareness Campaign PR Newswire (Canada) - 4/3/2018 8:00:00 AM
Salix Launches 'Let's Talk 2' IBS Awareness Campaign PR Newswire (US) - 4/3/2018 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 3/30/2018 4:34:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/27/2018 6:02:26 AM
Valeant and One of its Subsidiaries Announce Early Tender Results and Early Settlement Date for Cash Tender Offers for Senior... PR Newswire (Canada) - 3/26/2018 7:00:00 AM
Valeant and One of its Subsidiaries Announce Early Tender Results and Early Settlement Date for Cash Tender Offers for Senior... PR Newswire (US) - 3/26/2018 7:00:00 AM
ChrisJP Member Level  Friday, 11/10/17 12:09:13 PM
Re: UnderOath-KY post# 3886
Post # of 4480 
Hey I'd be happy with $25 - $30 by end of Jan 2018. smile

Chris


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist